Smiths Medical
Smiths Medical
Minneapolis, Minnesota, United States
Minneapolis, Minnesota, United States
Company Information
Smiths Medical offers a line of veterinary specific medical devices under the SurgiVet® brand that are recognized globally for their contributions in enhancing animal medicine. These devices are used in veterinary clinics, universities, and specialty areas such as zoos and aquatic centers around the world.
Company History
Our Purpose
Provide innovative solutions and superior support to help healthcare professionals and providers ensure safety, enhance patient outcomes, and improve the total cost of care.
At Smiths Medical, we are passionate about improving and saving the lives of patients through high quality, innovative medical devices and services. We are a leading global manufacturer of specialty medical devices that provides innovative and lifesaving solutions for the world’s healthcare markets. Specializing in Infusion Therapy, Vascular Access, Vital Care, and Specialty Products & Services, our products are found in hospital, emergency, home and specialty care environments and are used during critical and intensive care, surgery, post-operative care and for support in managing chronic illness.
Facts and Figures
Total Employees: 7,770
Global headquarters: Minneapolis, Minnesota, USA
Leadership: JehanZeb Noor, CEO
Corporate Parent: Smiths Group plc, a FTSE 100 UK based company
2019 Revenue: £874m
2019 Headline Operating Profit: £147m
Principal Operations Regions
We have operations in over 30 countries with manufacturing concentrated in the US, UK, Mexico, Italy, Germany, Czech Republic, and China. We sell to over 100 markets and, while the US continues to be our largest single market with around 45% of sales, we continue to build our presence in developing and emerging markets.
Customers and Distribution
Approximately three-quarters of our end user customers are hospitals with the remainder comprising the alternate care market, such as homecare, clinics, and other surgery centres, as well as OEM relationships. We have a direct sales presence in over 20 countries and distribution arrangements in approximately 100 others.
Our Product Portfolio
Infusion Therapy – Fluid and medication delivery devices for pain management and the treatment of acute and chronic diseases.
Vital Care – Devices for managing patients’ airways and body temperature before, during and after surgery.
Vascular Access – Devices providing healthcare professionals access to patients’ vasculature for delivery and withdrawal of fluid and medication, as well as devices to protect health workers by helping prevent needlestick injuries.
Speciality Products & Services – Products for clinicians and businesses in the specialized care areas of veterinary health, transport ventilation, patient monitoring and medical device manufacturing.
Provide innovative solutions and superior support to help healthcare professionals and providers ensure safety, enhance patient outcomes, and improve the total cost of care.
At Smiths Medical, we are passionate about improving and saving the lives of patients through high quality, innovative medical devices and services. We are a leading global manufacturer of specialty medical devices that provides innovative and lifesaving solutions for the world’s healthcare markets. Specializing in Infusion Therapy, Vascular Access, Vital Care, and Specialty Products & Services, our products are found in hospital, emergency, home and specialty care environments and are used during critical and intensive care, surgery, post-operative care and for support in managing chronic illness.
Facts and Figures
Total Employees: 7,770
Global headquarters: Minneapolis, Minnesota, USA
Leadership: JehanZeb Noor, CEO
Corporate Parent: Smiths Group plc, a FTSE 100 UK based company
2019 Revenue: £874m
2019 Headline Operating Profit: £147m
Principal Operations Regions
We have operations in over 30 countries with manufacturing concentrated in the US, UK, Mexico, Italy, Germany, Czech Republic, and China. We sell to over 100 markets and, while the US continues to be our largest single market with around 45% of sales, we continue to build our presence in developing and emerging markets.
Customers and Distribution
Approximately three-quarters of our end user customers are hospitals with the remainder comprising the alternate care market, such as homecare, clinics, and other surgery centres, as well as OEM relationships. We have a direct sales presence in over 20 countries and distribution arrangements in approximately 100 others.
Our Product Portfolio
Infusion Therapy – Fluid and medication delivery devices for pain management and the treatment of acute and chronic diseases.
Vital Care – Devices for managing patients’ airways and body temperature before, during and after surgery.
Vascular Access – Devices providing healthcare professionals access to patients’ vasculature for delivery and withdrawal of fluid and medication, as well as devices to protect health workers by helping prevent needlestick injuries.
Speciality Products & Services – Products for clinicians and businesses in the specialized care areas of veterinary health, transport ventilation, patient monitoring and medical device manufacturing.
No job openings
